COVID-19

Can telemedicine replace in-person visits? 3:34
Can telemedicine replace in-person visits?
Amy Guzik • 16 Apr 2021
Pathophysiology of acute and post-viral neurologic complications of COVID-19 6:39
Pathophysiology of acute and post-viral neurologic complications of COVID-19
Avindra Nath • 14 Apr 2021
Does COVID-19 enter the brain via the nose? 3:17
Does COVID-19 enter the brain via the nose?
Avindra Nath • 14 Apr 2021
Acute stroke care during the COVID-19 pandemic 4:53
Acute stroke care during the COVID-19 pandemic
Mitchell Elkind • 8 Apr 2021
Understanding the post-acute sequelae of SARS-CoV-2 infection (PASC) 3:51
Understanding the post-acute sequelae of SARS-CoV-2 infection (PASC)
Igor Koralnik • 6 Apr 2021
Investigating long-COVID and chronic fatigue syndrome 2:10
Investigating long-COVID and chronic fatigue syndrome
Avindra Nath • 14 Apr 2021
Neurological complications of COVID-19 in non-hospitalized Covid-19 “long haulers” 6:06
Neurological complications of COVID-19 in non-hospitalized Covid-19 “long haulers”
Igor Koralnik • 6 Apr 2021
Immune response and vaccines against SARS-CoV-2 9:39
Immune response and vaccines against SARS-CoV-2
Igor Koralnik • 6 Apr 2021
Infection and stroke: thromboinflammation and enhanced neurodegeneration 6:23
Infection and stroke: thromboinflammation and enhanced neurodegeneration
Mitchell Elkind • 8 Apr 2021
The AHA Don’t Die of Doubt stroke campaign 2:17
The AHA Don’t Die of Doubt stroke campaign
Mitchell Elkind • 8 Apr 2021
The Italian MS Society collaborative project on COVID-19 data collection 2:24
The Italian MS Society collaborative project on COVID-19 data collection
Maria Pia Sormani • 6 Apr 2021
Hot topics at AAN 2021: COVID-19 and racial disparities in neurologic care 1:45
Hot topics at AAN 2021: COVID-19 and racial disparities in neurologic care
Chantale Branson • 7 Apr 2021
Is there an association between AD and COVID-19? 2:02
Is there an association between AD and COVID-19?
Katja Kanninen • 17 Mar 2021
Genetic and environmental risk factors for iPD act synergistically via the immune system 3:39
Genetic and environmental risk factors for iPD act synergistically via the immune system
Malú Tansey • 8 Mar 2021
Unmet needs of Parkinson’s disease patients during the COVID-19 pandemic 1:47
Unmet needs of Parkinson’s disease patients during the COVID-19 pandemic
Rejko Krüger • 9 Mar 2021
COVID-19 severity in patients with MS 1:25
COVID-19 severity in patients with MS
Carlos Pérez • 25 Feb 2021
The content of VJNeurology is intended for healthcare professionals